Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 3
2010 2
2011 2
2012 2
2013 1
2014 2
2015 4
2016 1
2018 1
2020 1
2021 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.
Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators. Zannad F, et al. N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30146935 Free article. Clinical Trial.
Predicting sudden cardiac death in adults with congenital heart disease.
Oliver JM, Gallego P, Gonzalez AE, Avila P, Alonso A, Garcia-Hamilton D, Peinado R, Dos-Subirà L, Pijuan-Domenech A, Rueda J, Rodriguez-Puras MJ, Garcia-Orta R, Martínez-Quintana E, Datino T, Fernandez-Aviles F, Bermejo J; Spanish ACHD Network. Oliver JM, et al. Heart. 2021 Jan;107(1):67-75. doi: 10.1136/heartjnl-2020-316791. Epub 2020 Jun 16. Heart. 2021. PMID: 32546506
Subclinical Left Ventricular Systolic Dysfunction in Hospitalized Patients with COVID-19 by Strain: A 30-Day Echocardiographic Follow-Up.
Morillas-Blasco P, Guedes-Ramallo P, Vicente-Ibarra N, Martínez-Moreno M, Romero-Valero A, García-Honrubia A, Castilla-Cabanes E, Viedma-Contreras JA, Masiá-Canuto M, Castillo-Castillo J, Santos-Martínez S. Morillas-Blasco P, et al. Among authors: garcia honrubia a. Medicina (Kaunas). 2023 Nov 23;59(12):2065. doi: 10.3390/medicina59122065. Medicina (Kaunas). 2023. PMID: 38138168 Free PMC article.
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.
Montoro-García S, Hernández-Romero D, Jover E, García-Honrubia A, Vilchez JA, Casas T, Martínez P, Climent V, Caballero L, Valdés M, Marín F. Montoro-García S, et al. Among authors: garcia honrubia a. Eur J Intern Med. 2012 Mar;23(2):169-74. doi: 10.1016/j.ejim.2011.08.022. Epub 2011 Sep 15. Eur J Intern Med. 2012. PMID: 22284249
Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches.
Orenes-Piñero E, Hernández-Romero D, de Torre C, Vilchez JA, Martínez M, Romero-Aniorte AI, Climent V, García-Honrubia A, Valdés M, Marín F. Orenes-Piñero E, et al. Among authors: garcia honrubia a. Ann Med. 2013 Jun;45(4):341-7. doi: 10.3109/07853890.2013.792555. Epub 2013 May 23. Ann Med. 2013. PMID: 23701180 Free article.
19 results